EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Lower serum prohepcidin levels associated with lower iron and erythropoietin requirements in hemodialysis patients with chronic hepatitis C



Lower serum prohepcidin levels associated with lower iron and erythropoietin requirements in hemodialysis patients with chronic hepatitis C



Bmc Nephrology 13: 56-56



Patients with chronic HCV infection have increased liver iron. Recently identified protein hepcidin synthesized in the liver, is thought to be a key regulator for iron homeostasis and is induced by infection and inflammation. Lower erythropoietin and iron supplementation requirements were previously reported in HD patients with HCV infection. We investigated the association of prohepcidin with inflammation and iron parameters in HD patients with and without chronic HCV infection. Sixty patients (27 male, 33 female, mean age 50±15 years) on chronic HD were included. Parameters related to iron metabolism (ferritin, serum iron and total iron binding capacity (TIBC)), inflammation (hs-CRP, TNF-α and IL-6) and prohepcidin levels were measured. The response to treatment (erythropoiesis-stimulating agent (ESA) resistance index) was assessed from the ratio of the weekly erythropoietin (rhuEPO) dose to hemoglobin (Hb) per unit weight. Serum prohepcidin levels of HCV positive patients (135±25 ng/mL) were significantly lower than HCV negative patients [148±18 ng/mL, (p=0.025)]. Serum IL-6 levels of HCV positive patients were also significantly lower than HCV negative patients (p=0.016). Serum prohepcidin levels were positively correlated with ferritin (r=0.405, p=0.001) and IL-6 (r=0.271, p=0.050) levels in HD patients. In the HCV positive group, serum prohepcidin levels significantly correlated with ferritin levels (r=0.514 p=0.004). In the HCV negative group, serum prohepcidin levels significantly correlated with serum IL-6 levels (r=0.418, p=0.027). In multiple regression analysis performed to predict prohepcidin in HCV positive patients, serum ferritin was found to be an independent variable (r=0.28, p=0.008). HCV positive HD patients have low levels of serum prohepcidin and IL-6 which might account for iron accumulation together with lower iron and rhuEPO requirements in these patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 054192953

Download citation: RISBibTeXText

PMID: 22768976

DOI: 10.1186/1471-2369-13-56



Related references

Lower serum prohepcidin levels associated with lower iron and erythropoietn requirements in hemodialysis patients with chronic hepatitis C. 2012

Serum prohepcidin levels correlate with hepatic iron stores in chronic hepatitis C patients. Hepato-Gastroenterology 56(93): 1146-1151, 2009

Lower erythropoietin and iron supplementation are required in hemodialysis patients with hepatitis C virus infection. Clinical Nephrology 61(5): 347-351, 2004

Erythropoietin requirements are inversely related to iron saturation levels in chronic stable hemodialysis patients. Journal of the American Society of Nephrology 7(9): 1442, 1996

Serum prohepcidin levels are lower in patients with atrophic gastritis. Gastroenterology Research and Practice 2013: 201810-201810, 2013

Effect of hemodialysis procedure in prohepcidin serum levels in regular hemodialysis patients. Clinical Nephrology 71(2): 233-235, 2009

Lower initial serum vitamin B12 levels in Helicobacter pylori positive- compared to HP negative patients on chronic hemodialysis. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 415A, September, 2001

Influence of erythropoietin therapy on serum prohepcidin levels in dialysis patients. Medical Science Monitor 15(11): Cr583-7, 2010

Serum erythropoietin levels and body iron stores in hemodialysis patients. Journal of the American Society of Nephrology 4(3): 432, 1993

Serum erythropoietin and IL-6 levels in hemodialysis patients with hepatitis virus infection. Nephrology Dialysis Transplantation 12(9): A133, 1997

Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis. Acta Medica Portuguesa 5(7): 351-357, 1992

Serum erythropoietin concentrations and iron status in patients on chronic hemodialysis. Clinical Chemistry 38(2): 199-203, 1992

Serum erythropoietin and interleukin-6 levels in hemodialysis patients with hepatitis virus infection. Journal of Interferon & Cytokine Research 19(4): 369-373, 1999

Regulatory failure of serum prohepcidin levels in patients with hepatitis C. Hepatology Research 36(4): 288-293, 2006